Skip to main content
Back
CERT logo

Certara, Inc.

Data quality: 100%
CERT
NASDAQ Healthcare Medical - Healthcare Information Services
$6.35
▲ $0.20 (3.25%)
Mkt Cap: 1.01B
Day Range
$6.02 $6.40
52-Week Range
$6.02 $15.38
Volume
5,161,196
50D / 200D Avg
$7.73 / $9.93
Prev Close
$6.15

Price History

Financial Trends

Peer Comparison

vs Healthcare sector median (626 peers)

Metric Stock Sector Median
P/E -634.1 0.4
P/B 1.0 2.9
ROE % -0.2 3.8
Net Margin % -0.4 3.9
Rev Growth 5Y % 10.0 10.0
D/E 0.0 0.2

Key Takeaways

Revenue grew 10.00% annually over 5 years — strong growth
Debt/Equity of 0.01 — conservative balance sheet
Generating 94.57M in free cash flow
Capital efficient — spends only 0.42% of revenue on capex
ROIC of 1.47% — low return on invested capital
Interest coverage of 1.06× — tight debt servicing

Growth

Revenue Growth (5Y)
10.00%
Revenue (1Y)8.75%
Earnings (1Y)N/A
FCF Growth (3Y)8.06%

Quality

Return on Equity
-0.15%
ROIC1.47%
Net Margin-0.38%
Op. Margin5.02%

Safety

Debt / Equity
0.01
Current Ratio2.05
Interest Coverage1.06

Valuation

P/E Ratio
-634.10
P/B Ratio0.95
EV/EBITDA39.66
Dividend Yield0.00%

All Fundamental Metrics

Growth
Revenue Growth (1Y) 8.75% Revenue Growth (3Y) 8.72%
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) 10.00% Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 418.84M Net Income (TTM) -1.60M
ROE -0.15% ROA -0.10%
Gross Margin 61.53% Operating Margin 5.02%
Net Margin -0.38% Free Cash Flow (TTM) 94.57M
ROIC 1.47% FCF Growth (3Y) 8.06%
Safety
Debt / Equity 0.01 Current Ratio 2.05
Interest Coverage 1.06 Dividend Yield 0.00%
Valuation
P/E Ratio -634.10 P/B Ratio 0.95
P/S Ratio 2.41 PEG Ratio 10.22
EV/EBITDA 39.66 Dividend Yield 0.00%
Market Cap 1.01B Enterprise Value 833.39M

Income Statement

Annual, most recent first

Income statement data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 418.84M 385.15M 354.34M 335.64M 286.10M
Net Income -1.60M -12.05M -55.36M 14.73M -13.27M
EPS (Diluted) -0.01 -0.08 -0.35 0.09 -0.09
Gross Profit 257.71M 230.63M 213.32M 203.07M 174.49M
Operating Income 21.02M -1.73M -40.77M 32.52M 13.58M

Balance Sheet

Annual, most recent first

Balance sheet data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 1.56B 1.58B 1.56B 1.57B 1.51B
Total Liabilities 493.79M 516.45M 516.30M 493.26M 469.88M
Shareholders' Equity 1.06B 1.06B 1.05B 1.08B 1.04B
Total Debt 11.40M 311.90M 302.57M 308.13M 308.38M
Cash & Equivalents 189.39M 179.18M 234.95M 236.59M 185.80M
Current Assets 315.12M 310.85M 340.20M 342.25M 274.73M
Current Liabilities 153.39M 146.09M 130.02M 103.16M 92.23M

Strategy Scores

This stock passed the criteria for 1 strategy

Score = fit strength (0–100)
Rank = position among all matches
Custom Deep Value Investing (Seth Klarman)
#808 of 820
5

Recent Activity

Entered Deep Value Investing (Seth Klarman)
Mar 24, 2026